89
www.ecio.org C RSE Seventh European Conference on Interventional Oncology April 17-20, 2016 Dublin, Ireland EC IO 2016 POCKET GUIDE Cardiovascular and Interventional Radiological Society of Europe LEADERS IN ONCOLOGIC INTERVENTIONS

ECIO 2016 Pocket Guide - Amazon Web Services · 2 Important Addresses 3 Committees 4 General Information 10 Honorary Lecture 12 Hands-on Workshops Corporate Activities 39 Satellite

Embed Size (px)

Citation preview

wwwecioorg

C RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

POCKET GUIDE

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

MO

NS

UN

TU

EW

ED

2

17

23

29

35

37

54

Sunday ndash Scientific Programme

Monday ndash Scientific Programme

Tuesday ndash Scientific Programme

Wednesday ndash Scientific Programme

2 Important Addresses

3 Committees

4 General Information

10 Honorary Lecture

12 Hands-on Workshops

Corporate Activities

39 Satellite Symposia

51 Hands-on Workshop Sponsors

Exhibitors and Sponsors

54 Sponsors

57 Technical Exhibition Alphabetical List

59 Technical Exhibition Numerical List

61 Technical Exhibitors Guide

Important Addresses

Congress Venue

The Convention Centre Dublin

Spencer Dock

Dublin 1

Ireland

Organising Secretariat

CIRSE Central Office

Neutorgasse 9

1010 Vienna

Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-Mail infocirseorg

Web wwwecioorg

C RSE

2 ECIO ndash European Conference on Interventional Oncology

Important Addresses Committees

Committees

Advisory Board

Andreas Adam (UK)

Thierry de Baegravere (FR)

Johannes Lammer (AT)

Riccardo Lencioni (US)

Jan H Peregrin (CZ)

Jim A Reekers (NL)

Scientific Programme Committee

Thomas K Helmberger (DE) Chairperson

Afshin Gangi (FR) Deputy Chairperson

Jose I Bilbao (ES)

Christoph A Binkert (CH)

Elias Brountzos (GR)

Thierry de Baegravere (FR)

Alban Denys (CH)

Jean-Franccedilois H Geschwind (US)

Bernd Hamm (DE)

Michael J Lee (IE)

Katerina Malagari (GR)

Philippe L Pereira (DE)

Local Host Committee

Michael J Lee (Dublin) Chairperson

Colin Cantwell (Dublin)

Tony Geoghegan (Dublin)

Peter Kennedy (Belfast)

Gerard J OSullivan (Galway)

Anthony G Ryan (Waterford City)

Mark Ryan (Dublin)

William Torreggiani (Dublin)

David Tuite (Cork)

The European Conference on Interventional Oncology

is organised by CIRSE (Cardiovascular and Interventional

Radiological Society of Europe)

The official congress website is wwwecioorg

To contact the CIRSE Central Office or members of the

committee please write to infocirseorg

3

Cardiovascular and Interventional Radiological Society of Europe

4 ECIO ndash European Conference on Interventional Oncology

General Information from A to Z

App

Let the CIRSE app take care of your congress planning New-

comers please download the CIRSE society app which is

available for iPhone iPad and Android (wwwcirseorgapp)

and install the ECIO 2016 event If the CIRSE society app is

already on your smartphone please just install the ECIO 2016

event and have the best toolkit to plan your personal con -

gress programme evaluate sessions browse the exhibition

take part in votings and submit questions to the moderator

in selected sessions

Badges

Your personalised badge is your admission card to the

congress For organisational and security reasons badges

must be worn at the congress venue at all times A lanyard

will be given to you with the congress bag Identity checks

in the congress centre may occur at any time In case of loss

a replacement badge will be provided for an administrative

charge of euro80

Certificate of Attendance

To obtain your certificate of attendance you can choose one

of the following options

Print your certificate onsite at the congress

From 1000 on Tuesday April 19 you can use one of the

dedicated workstations in the registration area to print your

certificate All you need is your congress badge

Print your certificate at home

After the congress you will be able to print your certificate

of attendance at wwwecioorg All you will need is your last

name and badge number Alternatively you could log into

your personal CIRSE account at wwwcirseorg with your per-

sonal log-in details

C RSE

5

Cardiovascular and Interventional Radiological Society of Europe

General Information 5

CME Credit Allowance

CIRSE is accredited by the European Accreditation Council

for Continuing Medical Education (EACCME) to provide the

following CME activity for medical specialists The EACCME

is an institution of the European Union of Medical Specialists

(UEMS) wwwuemsnet

ECIO 2016 is designated for up to 21 hours of European

external CME credits Each medical specialist should claim

only those hours of credit that heshe actually spent in the

educational activity

Through an agreement between the European Union of

Medical Specialists and the American Medical Association

physicians may convert EACCME credits to an equivalent

number of AMA PRA Category 1 Creditstrade Information on the

process to convert EACCME credit to AMA credit can be found

at wwwama-assnorggointernationalcme

Live educational activities occurring outside of Canada

recognised by the UEMS-EACCME for ECMEC credits are

deemed to be Accredited Group Learning Activities (Section 1)

as defined by the Maintenance of Certification Program of The

Royal College of Physicians and Surgeons of Canada

Coffee Breaks Snacks amp Meals

During the breaks refreshments can be purchased at the

Liffey Bar located on the first floor foyer

The Liffey Bar opens at 0900

A complimentary lunch buffet and afternoon refreshments

provided by the sponsors of the lunch symposia will be avail-

able in the exhibition area Lunch will be from 1200-1300

and the afternoon break will be from 1630-1700

Disclaimer

CIRSE cannot accept any liability for the acts of the suppliers

to this meeting or the attendeesrsquo safety while travelling to

or from the congress All participants are strongly advised to

carry adequate travel and health insurance as CIRSE cannot

accept liability for accidents or injuries that may occur

C RSE

6 ECIO ndash European Conference on Interventional Oncology

Disclosures

For financial disclosures and conflict of interest statements

please refer to wwwecioorg

ESIRonline ndash wwwesirorg

ESIRonline is the largest online presentation database for

interventional radiology featuring slides and webcasts from

CIRSE meetings since 2006 With a large section covering

oncology topics ESIRonline is the ideal tool for your research

and educational needs Presentations recorded at ECIO 2016

will be integrated shortly after the meeting Access to all

content is free for CIRSE members and year-round access is

included with an ECIO 2016 registration

Evaluation

To complete the session evaluation and obtain credits for

your attendance at ECIO 2016 sessions please use the online

evaluation system accessible through the CIRSE mobile app

(please see page 4) and at httpsevalwebgescomecio2016

Internet

A free wireless service is available to all delegates throughout

the congress centre

Network ECIO2016

Password ecio2016

Mobile Phones

Please do not forget to turn your mobile phone to silent

mode during the sessions

Recording and Photographs

Please note that any form of recording filming or photo-

graphing of presentation material during the sessions is

strictly forbidden Subject to the authorsrsquo consent all pres-

entation material will be made available online on CIRSErsquos

educational platform ESIRonline

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

MO

NS

UN

TU

EW

ED

2

17

23

29

35

37

54

Sunday ndash Scientific Programme

Monday ndash Scientific Programme

Tuesday ndash Scientific Programme

Wednesday ndash Scientific Programme

2 Important Addresses

3 Committees

4 General Information

10 Honorary Lecture

12 Hands-on Workshops

Corporate Activities

39 Satellite Symposia

51 Hands-on Workshop Sponsors

Exhibitors and Sponsors

54 Sponsors

57 Technical Exhibition Alphabetical List

59 Technical Exhibition Numerical List

61 Technical Exhibitors Guide

Important Addresses

Congress Venue

The Convention Centre Dublin

Spencer Dock

Dublin 1

Ireland

Organising Secretariat

CIRSE Central Office

Neutorgasse 9

1010 Vienna

Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-Mail infocirseorg

Web wwwecioorg

C RSE

2 ECIO ndash European Conference on Interventional Oncology

Important Addresses Committees

Committees

Advisory Board

Andreas Adam (UK)

Thierry de Baegravere (FR)

Johannes Lammer (AT)

Riccardo Lencioni (US)

Jan H Peregrin (CZ)

Jim A Reekers (NL)

Scientific Programme Committee

Thomas K Helmberger (DE) Chairperson

Afshin Gangi (FR) Deputy Chairperson

Jose I Bilbao (ES)

Christoph A Binkert (CH)

Elias Brountzos (GR)

Thierry de Baegravere (FR)

Alban Denys (CH)

Jean-Franccedilois H Geschwind (US)

Bernd Hamm (DE)

Michael J Lee (IE)

Katerina Malagari (GR)

Philippe L Pereira (DE)

Local Host Committee

Michael J Lee (Dublin) Chairperson

Colin Cantwell (Dublin)

Tony Geoghegan (Dublin)

Peter Kennedy (Belfast)

Gerard J OSullivan (Galway)

Anthony G Ryan (Waterford City)

Mark Ryan (Dublin)

William Torreggiani (Dublin)

David Tuite (Cork)

The European Conference on Interventional Oncology

is organised by CIRSE (Cardiovascular and Interventional

Radiological Society of Europe)

The official congress website is wwwecioorg

To contact the CIRSE Central Office or members of the

committee please write to infocirseorg

3

Cardiovascular and Interventional Radiological Society of Europe

4 ECIO ndash European Conference on Interventional Oncology

General Information from A to Z

App

Let the CIRSE app take care of your congress planning New-

comers please download the CIRSE society app which is

available for iPhone iPad and Android (wwwcirseorgapp)

and install the ECIO 2016 event If the CIRSE society app is

already on your smartphone please just install the ECIO 2016

event and have the best toolkit to plan your personal con -

gress programme evaluate sessions browse the exhibition

take part in votings and submit questions to the moderator

in selected sessions

Badges

Your personalised badge is your admission card to the

congress For organisational and security reasons badges

must be worn at the congress venue at all times A lanyard

will be given to you with the congress bag Identity checks

in the congress centre may occur at any time In case of loss

a replacement badge will be provided for an administrative

charge of euro80

Certificate of Attendance

To obtain your certificate of attendance you can choose one

of the following options

Print your certificate onsite at the congress

From 1000 on Tuesday April 19 you can use one of the

dedicated workstations in the registration area to print your

certificate All you need is your congress badge

Print your certificate at home

After the congress you will be able to print your certificate

of attendance at wwwecioorg All you will need is your last

name and badge number Alternatively you could log into

your personal CIRSE account at wwwcirseorg with your per-

sonal log-in details

C RSE

5

Cardiovascular and Interventional Radiological Society of Europe

General Information 5

CME Credit Allowance

CIRSE is accredited by the European Accreditation Council

for Continuing Medical Education (EACCME) to provide the

following CME activity for medical specialists The EACCME

is an institution of the European Union of Medical Specialists

(UEMS) wwwuemsnet

ECIO 2016 is designated for up to 21 hours of European

external CME credits Each medical specialist should claim

only those hours of credit that heshe actually spent in the

educational activity

Through an agreement between the European Union of

Medical Specialists and the American Medical Association

physicians may convert EACCME credits to an equivalent

number of AMA PRA Category 1 Creditstrade Information on the

process to convert EACCME credit to AMA credit can be found

at wwwama-assnorggointernationalcme

Live educational activities occurring outside of Canada

recognised by the UEMS-EACCME for ECMEC credits are

deemed to be Accredited Group Learning Activities (Section 1)

as defined by the Maintenance of Certification Program of The

Royal College of Physicians and Surgeons of Canada

Coffee Breaks Snacks amp Meals

During the breaks refreshments can be purchased at the

Liffey Bar located on the first floor foyer

The Liffey Bar opens at 0900

A complimentary lunch buffet and afternoon refreshments

provided by the sponsors of the lunch symposia will be avail-

able in the exhibition area Lunch will be from 1200-1300

and the afternoon break will be from 1630-1700

Disclaimer

CIRSE cannot accept any liability for the acts of the suppliers

to this meeting or the attendeesrsquo safety while travelling to

or from the congress All participants are strongly advised to

carry adequate travel and health insurance as CIRSE cannot

accept liability for accidents or injuries that may occur

C RSE

6 ECIO ndash European Conference on Interventional Oncology

Disclosures

For financial disclosures and conflict of interest statements

please refer to wwwecioorg

ESIRonline ndash wwwesirorg

ESIRonline is the largest online presentation database for

interventional radiology featuring slides and webcasts from

CIRSE meetings since 2006 With a large section covering

oncology topics ESIRonline is the ideal tool for your research

and educational needs Presentations recorded at ECIO 2016

will be integrated shortly after the meeting Access to all

content is free for CIRSE members and year-round access is

included with an ECIO 2016 registration

Evaluation

To complete the session evaluation and obtain credits for

your attendance at ECIO 2016 sessions please use the online

evaluation system accessible through the CIRSE mobile app

(please see page 4) and at httpsevalwebgescomecio2016

Internet

A free wireless service is available to all delegates throughout

the congress centre

Network ECIO2016

Password ecio2016

Mobile Phones

Please do not forget to turn your mobile phone to silent

mode during the sessions

Recording and Photographs

Please note that any form of recording filming or photo-

graphing of presentation material during the sessions is

strictly forbidden Subject to the authorsrsquo consent all pres-

entation material will be made available online on CIRSErsquos

educational platform ESIRonline

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Important Addresses

Congress Venue

The Convention Centre Dublin

Spencer Dock

Dublin 1

Ireland

Organising Secretariat

CIRSE Central Office

Neutorgasse 9

1010 Vienna

Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-Mail infocirseorg

Web wwwecioorg

C RSE

2 ECIO ndash European Conference on Interventional Oncology

Important Addresses Committees

Committees

Advisory Board

Andreas Adam (UK)

Thierry de Baegravere (FR)

Johannes Lammer (AT)

Riccardo Lencioni (US)

Jan H Peregrin (CZ)

Jim A Reekers (NL)

Scientific Programme Committee

Thomas K Helmberger (DE) Chairperson

Afshin Gangi (FR) Deputy Chairperson

Jose I Bilbao (ES)

Christoph A Binkert (CH)

Elias Brountzos (GR)

Thierry de Baegravere (FR)

Alban Denys (CH)

Jean-Franccedilois H Geschwind (US)

Bernd Hamm (DE)

Michael J Lee (IE)

Katerina Malagari (GR)

Philippe L Pereira (DE)

Local Host Committee

Michael J Lee (Dublin) Chairperson

Colin Cantwell (Dublin)

Tony Geoghegan (Dublin)

Peter Kennedy (Belfast)

Gerard J OSullivan (Galway)

Anthony G Ryan (Waterford City)

Mark Ryan (Dublin)

William Torreggiani (Dublin)

David Tuite (Cork)

The European Conference on Interventional Oncology

is organised by CIRSE (Cardiovascular and Interventional

Radiological Society of Europe)

The official congress website is wwwecioorg

To contact the CIRSE Central Office or members of the

committee please write to infocirseorg

3

Cardiovascular and Interventional Radiological Society of Europe

4 ECIO ndash European Conference on Interventional Oncology

General Information from A to Z

App

Let the CIRSE app take care of your congress planning New-

comers please download the CIRSE society app which is

available for iPhone iPad and Android (wwwcirseorgapp)

and install the ECIO 2016 event If the CIRSE society app is

already on your smartphone please just install the ECIO 2016

event and have the best toolkit to plan your personal con -

gress programme evaluate sessions browse the exhibition

take part in votings and submit questions to the moderator

in selected sessions

Badges

Your personalised badge is your admission card to the

congress For organisational and security reasons badges

must be worn at the congress venue at all times A lanyard

will be given to you with the congress bag Identity checks

in the congress centre may occur at any time In case of loss

a replacement badge will be provided for an administrative

charge of euro80

Certificate of Attendance

To obtain your certificate of attendance you can choose one

of the following options

Print your certificate onsite at the congress

From 1000 on Tuesday April 19 you can use one of the

dedicated workstations in the registration area to print your

certificate All you need is your congress badge

Print your certificate at home

After the congress you will be able to print your certificate

of attendance at wwwecioorg All you will need is your last

name and badge number Alternatively you could log into

your personal CIRSE account at wwwcirseorg with your per-

sonal log-in details

C RSE

5

Cardiovascular and Interventional Radiological Society of Europe

General Information 5

CME Credit Allowance

CIRSE is accredited by the European Accreditation Council

for Continuing Medical Education (EACCME) to provide the

following CME activity for medical specialists The EACCME

is an institution of the European Union of Medical Specialists

(UEMS) wwwuemsnet

ECIO 2016 is designated for up to 21 hours of European

external CME credits Each medical specialist should claim

only those hours of credit that heshe actually spent in the

educational activity

Through an agreement between the European Union of

Medical Specialists and the American Medical Association

physicians may convert EACCME credits to an equivalent

number of AMA PRA Category 1 Creditstrade Information on the

process to convert EACCME credit to AMA credit can be found

at wwwama-assnorggointernationalcme

Live educational activities occurring outside of Canada

recognised by the UEMS-EACCME for ECMEC credits are

deemed to be Accredited Group Learning Activities (Section 1)

as defined by the Maintenance of Certification Program of The

Royal College of Physicians and Surgeons of Canada

Coffee Breaks Snacks amp Meals

During the breaks refreshments can be purchased at the

Liffey Bar located on the first floor foyer

The Liffey Bar opens at 0900

A complimentary lunch buffet and afternoon refreshments

provided by the sponsors of the lunch symposia will be avail-

able in the exhibition area Lunch will be from 1200-1300

and the afternoon break will be from 1630-1700

Disclaimer

CIRSE cannot accept any liability for the acts of the suppliers

to this meeting or the attendeesrsquo safety while travelling to

or from the congress All participants are strongly advised to

carry adequate travel and health insurance as CIRSE cannot

accept liability for accidents or injuries that may occur

C RSE

6 ECIO ndash European Conference on Interventional Oncology

Disclosures

For financial disclosures and conflict of interest statements

please refer to wwwecioorg

ESIRonline ndash wwwesirorg

ESIRonline is the largest online presentation database for

interventional radiology featuring slides and webcasts from

CIRSE meetings since 2006 With a large section covering

oncology topics ESIRonline is the ideal tool for your research

and educational needs Presentations recorded at ECIO 2016

will be integrated shortly after the meeting Access to all

content is free for CIRSE members and year-round access is

included with an ECIO 2016 registration

Evaluation

To complete the session evaluation and obtain credits for

your attendance at ECIO 2016 sessions please use the online

evaluation system accessible through the CIRSE mobile app

(please see page 4) and at httpsevalwebgescomecio2016

Internet

A free wireless service is available to all delegates throughout

the congress centre

Network ECIO2016

Password ecio2016

Mobile Phones

Please do not forget to turn your mobile phone to silent

mode during the sessions

Recording and Photographs

Please note that any form of recording filming or photo-

graphing of presentation material during the sessions is

strictly forbidden Subject to the authorsrsquo consent all pres-

entation material will be made available online on CIRSErsquos

educational platform ESIRonline

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Important Addresses Committees

Committees

Advisory Board

Andreas Adam (UK)

Thierry de Baegravere (FR)

Johannes Lammer (AT)

Riccardo Lencioni (US)

Jan H Peregrin (CZ)

Jim A Reekers (NL)

Scientific Programme Committee

Thomas K Helmberger (DE) Chairperson

Afshin Gangi (FR) Deputy Chairperson

Jose I Bilbao (ES)

Christoph A Binkert (CH)

Elias Brountzos (GR)

Thierry de Baegravere (FR)

Alban Denys (CH)

Jean-Franccedilois H Geschwind (US)

Bernd Hamm (DE)

Michael J Lee (IE)

Katerina Malagari (GR)

Philippe L Pereira (DE)

Local Host Committee

Michael J Lee (Dublin) Chairperson

Colin Cantwell (Dublin)

Tony Geoghegan (Dublin)

Peter Kennedy (Belfast)

Gerard J OSullivan (Galway)

Anthony G Ryan (Waterford City)

Mark Ryan (Dublin)

William Torreggiani (Dublin)

David Tuite (Cork)

The European Conference on Interventional Oncology

is organised by CIRSE (Cardiovascular and Interventional

Radiological Society of Europe)

The official congress website is wwwecioorg

To contact the CIRSE Central Office or members of the

committee please write to infocirseorg

3

Cardiovascular and Interventional Radiological Society of Europe

4 ECIO ndash European Conference on Interventional Oncology

General Information from A to Z

App

Let the CIRSE app take care of your congress planning New-

comers please download the CIRSE society app which is

available for iPhone iPad and Android (wwwcirseorgapp)

and install the ECIO 2016 event If the CIRSE society app is

already on your smartphone please just install the ECIO 2016

event and have the best toolkit to plan your personal con -

gress programme evaluate sessions browse the exhibition

take part in votings and submit questions to the moderator

in selected sessions

Badges

Your personalised badge is your admission card to the

congress For organisational and security reasons badges

must be worn at the congress venue at all times A lanyard

will be given to you with the congress bag Identity checks

in the congress centre may occur at any time In case of loss

a replacement badge will be provided for an administrative

charge of euro80

Certificate of Attendance

To obtain your certificate of attendance you can choose one

of the following options

Print your certificate onsite at the congress

From 1000 on Tuesday April 19 you can use one of the

dedicated workstations in the registration area to print your

certificate All you need is your congress badge

Print your certificate at home

After the congress you will be able to print your certificate

of attendance at wwwecioorg All you will need is your last

name and badge number Alternatively you could log into

your personal CIRSE account at wwwcirseorg with your per-

sonal log-in details

C RSE

5

Cardiovascular and Interventional Radiological Society of Europe

General Information 5

CME Credit Allowance

CIRSE is accredited by the European Accreditation Council

for Continuing Medical Education (EACCME) to provide the

following CME activity for medical specialists The EACCME

is an institution of the European Union of Medical Specialists

(UEMS) wwwuemsnet

ECIO 2016 is designated for up to 21 hours of European

external CME credits Each medical specialist should claim

only those hours of credit that heshe actually spent in the

educational activity

Through an agreement between the European Union of

Medical Specialists and the American Medical Association

physicians may convert EACCME credits to an equivalent

number of AMA PRA Category 1 Creditstrade Information on the

process to convert EACCME credit to AMA credit can be found

at wwwama-assnorggointernationalcme

Live educational activities occurring outside of Canada

recognised by the UEMS-EACCME for ECMEC credits are

deemed to be Accredited Group Learning Activities (Section 1)

as defined by the Maintenance of Certification Program of The

Royal College of Physicians and Surgeons of Canada

Coffee Breaks Snacks amp Meals

During the breaks refreshments can be purchased at the

Liffey Bar located on the first floor foyer

The Liffey Bar opens at 0900

A complimentary lunch buffet and afternoon refreshments

provided by the sponsors of the lunch symposia will be avail-

able in the exhibition area Lunch will be from 1200-1300

and the afternoon break will be from 1630-1700

Disclaimer

CIRSE cannot accept any liability for the acts of the suppliers

to this meeting or the attendeesrsquo safety while travelling to

or from the congress All participants are strongly advised to

carry adequate travel and health insurance as CIRSE cannot

accept liability for accidents or injuries that may occur

C RSE

6 ECIO ndash European Conference on Interventional Oncology

Disclosures

For financial disclosures and conflict of interest statements

please refer to wwwecioorg

ESIRonline ndash wwwesirorg

ESIRonline is the largest online presentation database for

interventional radiology featuring slides and webcasts from

CIRSE meetings since 2006 With a large section covering

oncology topics ESIRonline is the ideal tool for your research

and educational needs Presentations recorded at ECIO 2016

will be integrated shortly after the meeting Access to all

content is free for CIRSE members and year-round access is

included with an ECIO 2016 registration

Evaluation

To complete the session evaluation and obtain credits for

your attendance at ECIO 2016 sessions please use the online

evaluation system accessible through the CIRSE mobile app

(please see page 4) and at httpsevalwebgescomecio2016

Internet

A free wireless service is available to all delegates throughout

the congress centre

Network ECIO2016

Password ecio2016

Mobile Phones

Please do not forget to turn your mobile phone to silent

mode during the sessions

Recording and Photographs

Please note that any form of recording filming or photo-

graphing of presentation material during the sessions is

strictly forbidden Subject to the authorsrsquo consent all pres-

entation material will be made available online on CIRSErsquos

educational platform ESIRonline

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

4 ECIO ndash European Conference on Interventional Oncology

General Information from A to Z

App

Let the CIRSE app take care of your congress planning New-

comers please download the CIRSE society app which is

available for iPhone iPad and Android (wwwcirseorgapp)

and install the ECIO 2016 event If the CIRSE society app is

already on your smartphone please just install the ECIO 2016

event and have the best toolkit to plan your personal con -

gress programme evaluate sessions browse the exhibition

take part in votings and submit questions to the moderator

in selected sessions

Badges

Your personalised badge is your admission card to the

congress For organisational and security reasons badges

must be worn at the congress venue at all times A lanyard

will be given to you with the congress bag Identity checks

in the congress centre may occur at any time In case of loss

a replacement badge will be provided for an administrative

charge of euro80

Certificate of Attendance

To obtain your certificate of attendance you can choose one

of the following options

Print your certificate onsite at the congress

From 1000 on Tuesday April 19 you can use one of the

dedicated workstations in the registration area to print your

certificate All you need is your congress badge

Print your certificate at home

After the congress you will be able to print your certificate

of attendance at wwwecioorg All you will need is your last

name and badge number Alternatively you could log into

your personal CIRSE account at wwwcirseorg with your per-

sonal log-in details

C RSE

5

Cardiovascular and Interventional Radiological Society of Europe

General Information 5

CME Credit Allowance

CIRSE is accredited by the European Accreditation Council

for Continuing Medical Education (EACCME) to provide the

following CME activity for medical specialists The EACCME

is an institution of the European Union of Medical Specialists

(UEMS) wwwuemsnet

ECIO 2016 is designated for up to 21 hours of European

external CME credits Each medical specialist should claim

only those hours of credit that heshe actually spent in the

educational activity

Through an agreement between the European Union of

Medical Specialists and the American Medical Association

physicians may convert EACCME credits to an equivalent

number of AMA PRA Category 1 Creditstrade Information on the

process to convert EACCME credit to AMA credit can be found

at wwwama-assnorggointernationalcme

Live educational activities occurring outside of Canada

recognised by the UEMS-EACCME for ECMEC credits are

deemed to be Accredited Group Learning Activities (Section 1)

as defined by the Maintenance of Certification Program of The

Royal College of Physicians and Surgeons of Canada

Coffee Breaks Snacks amp Meals

During the breaks refreshments can be purchased at the

Liffey Bar located on the first floor foyer

The Liffey Bar opens at 0900

A complimentary lunch buffet and afternoon refreshments

provided by the sponsors of the lunch symposia will be avail-

able in the exhibition area Lunch will be from 1200-1300

and the afternoon break will be from 1630-1700

Disclaimer

CIRSE cannot accept any liability for the acts of the suppliers

to this meeting or the attendeesrsquo safety while travelling to

or from the congress All participants are strongly advised to

carry adequate travel and health insurance as CIRSE cannot

accept liability for accidents or injuries that may occur

C RSE

6 ECIO ndash European Conference on Interventional Oncology

Disclosures

For financial disclosures and conflict of interest statements

please refer to wwwecioorg

ESIRonline ndash wwwesirorg

ESIRonline is the largest online presentation database for

interventional radiology featuring slides and webcasts from

CIRSE meetings since 2006 With a large section covering

oncology topics ESIRonline is the ideal tool for your research

and educational needs Presentations recorded at ECIO 2016

will be integrated shortly after the meeting Access to all

content is free for CIRSE members and year-round access is

included with an ECIO 2016 registration

Evaluation

To complete the session evaluation and obtain credits for

your attendance at ECIO 2016 sessions please use the online

evaluation system accessible through the CIRSE mobile app

(please see page 4) and at httpsevalwebgescomecio2016

Internet

A free wireless service is available to all delegates throughout

the congress centre

Network ECIO2016

Password ecio2016

Mobile Phones

Please do not forget to turn your mobile phone to silent

mode during the sessions

Recording and Photographs

Please note that any form of recording filming or photo-

graphing of presentation material during the sessions is

strictly forbidden Subject to the authorsrsquo consent all pres-

entation material will be made available online on CIRSErsquos

educational platform ESIRonline

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

5

Cardiovascular and Interventional Radiological Society of Europe

General Information 5

CME Credit Allowance

CIRSE is accredited by the European Accreditation Council

for Continuing Medical Education (EACCME) to provide the

following CME activity for medical specialists The EACCME

is an institution of the European Union of Medical Specialists

(UEMS) wwwuemsnet

ECIO 2016 is designated for up to 21 hours of European

external CME credits Each medical specialist should claim

only those hours of credit that heshe actually spent in the

educational activity

Through an agreement between the European Union of

Medical Specialists and the American Medical Association

physicians may convert EACCME credits to an equivalent

number of AMA PRA Category 1 Creditstrade Information on the

process to convert EACCME credit to AMA credit can be found

at wwwama-assnorggointernationalcme

Live educational activities occurring outside of Canada

recognised by the UEMS-EACCME for ECMEC credits are

deemed to be Accredited Group Learning Activities (Section 1)

as defined by the Maintenance of Certification Program of The

Royal College of Physicians and Surgeons of Canada

Coffee Breaks Snacks amp Meals

During the breaks refreshments can be purchased at the

Liffey Bar located on the first floor foyer

The Liffey Bar opens at 0900

A complimentary lunch buffet and afternoon refreshments

provided by the sponsors of the lunch symposia will be avail-

able in the exhibition area Lunch will be from 1200-1300

and the afternoon break will be from 1630-1700

Disclaimer

CIRSE cannot accept any liability for the acts of the suppliers

to this meeting or the attendeesrsquo safety while travelling to

or from the congress All participants are strongly advised to

carry adequate travel and health insurance as CIRSE cannot

accept liability for accidents or injuries that may occur

C RSE

6 ECIO ndash European Conference on Interventional Oncology

Disclosures

For financial disclosures and conflict of interest statements

please refer to wwwecioorg

ESIRonline ndash wwwesirorg

ESIRonline is the largest online presentation database for

interventional radiology featuring slides and webcasts from

CIRSE meetings since 2006 With a large section covering

oncology topics ESIRonline is the ideal tool for your research

and educational needs Presentations recorded at ECIO 2016

will be integrated shortly after the meeting Access to all

content is free for CIRSE members and year-round access is

included with an ECIO 2016 registration

Evaluation

To complete the session evaluation and obtain credits for

your attendance at ECIO 2016 sessions please use the online

evaluation system accessible through the CIRSE mobile app

(please see page 4) and at httpsevalwebgescomecio2016

Internet

A free wireless service is available to all delegates throughout

the congress centre

Network ECIO2016

Password ecio2016

Mobile Phones

Please do not forget to turn your mobile phone to silent

mode during the sessions

Recording and Photographs

Please note that any form of recording filming or photo-

graphing of presentation material during the sessions is

strictly forbidden Subject to the authorsrsquo consent all pres-

entation material will be made available online on CIRSErsquos

educational platform ESIRonline

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

C RSE

6 ECIO ndash European Conference on Interventional Oncology

Disclosures

For financial disclosures and conflict of interest statements

please refer to wwwecioorg

ESIRonline ndash wwwesirorg

ESIRonline is the largest online presentation database for

interventional radiology featuring slides and webcasts from

CIRSE meetings since 2006 With a large section covering

oncology topics ESIRonline is the ideal tool for your research

and educational needs Presentations recorded at ECIO 2016

will be integrated shortly after the meeting Access to all

content is free for CIRSE members and year-round access is

included with an ECIO 2016 registration

Evaluation

To complete the session evaluation and obtain credits for

your attendance at ECIO 2016 sessions please use the online

evaluation system accessible through the CIRSE mobile app

(please see page 4) and at httpsevalwebgescomecio2016

Internet

A free wireless service is available to all delegates throughout

the congress centre

Network ECIO2016

Password ecio2016

Mobile Phones

Please do not forget to turn your mobile phone to silent

mode during the sessions

Recording and Photographs

Please note that any form of recording filming or photo-

graphing of presentation material during the sessions is

strictly forbidden Subject to the authorsrsquo consent all pres-

entation material will be made available online on CIRSErsquos

educational platform ESIRonline

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

General Information 7

Registration Desk ndash Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1800

Monday April 18 0730-1800

Tuesday April 19 0730-1800

Wednesday April 20 0800-1100

Smoking

The ECIO Annual Meeting is a non-smoking congress

Smoking is permitted outside the congress centre only

Speaker Centre

The Speaker Centre is located on the first floor of the

congress centre in Liffey Meeting Room 2a Please note that

only digital material will be allowed for oral presentations

All material must be in English and provided on a CD-ROM

DVD-ROM or USB flash drive (which is preferred) to be placed

on the central server onsite All presentation files must be

uploaded at least 3 hours prior to the beginning of the

corresponding session

Computers connected to the local server allowing access

to the speakersrsquo presentations are available in every lecture

room These computers are equipped with Microsoft

Windows 7 Professional and Microsoft Office 2013 Pro-

fessional Please note that speakers are not allowed to use

their own laptops for their presentations

Opening Hours

Saturday April 16 1600-1800

Sunday April 17 0730-1900

Monday April 18 0730-1900

Tuesday April 19 0730-1900

Wednesday April 20 0800-1200

Sponsors and Exhibitors

Please find a floor plan of the exhibition on the inside of the

front cover and a detailed list of all exhibitors and sponsors

on pages 54ndash83

Cardiovascular and Interventional Radiological Society of Europe

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

8

Opening Hours

Sunday April 17 0930-1730

Monday April 18 0930-1730

Tuesday April 19 0930-1730

Wednesday April 20 0930-1230

Tourist Information and Hospitality Desk

For information regarding restaurants and excursions please

refer to the desk of our official travel partner Kuoni located in

the registration area Kuoni will be pleased to help you with

all matters related to your stay in Dublin

ECIO ndash European Conference on Interventional Oncology

C RSE

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

9General Information

Cardiovascular and Interventional Radiological Society of EuropeCardiovascular and Interventional Radiological Society of Europe

G E T YO U R E C I O P R O G R A M M E

VIA THE CIRSE SOCIETY APP

I N N O V A T I O N | E D U C A T I O N | I N T E R V E N T I O N

Make the most of your time at ECIO 2016

bull participate in e-voting polls

bull evaluate sessions (see p6)

bull send questions to the moderators

bull build your personal schedule

bull navigate the exhibition

bull and much more

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Leaders in Oncologic Interventions

Bruno SangroHonorary Lecturer

Prof Bruno Sangro attained his medical degree from the

Universidad Complutense in Madrid in 1983 and trained

in medical oncology at the Hospital Cliacutenico de San Carlos

before moving to Pamplona After completing a residency

programme in internal medicine he joined the Liver Unit

at Cliacutenica Universidad de Navarra where he has spent the

remainder of his career He is now Director of the Liver Unit

and Co-Director of the HPB Oncology Area He has a strong

interest in teaching pre- and post-graduate medical students

and is now a full professor in the School of Medicine

Over the years his interest in medical research has focused

on therapeutic innovation in the field of liver diseases ndash most

specifically primary and secondary liver cancer Since earning

his PhD he has served as principal investigator of the

Therapeutic Strategies in Liver Disease group in the National

Network on Research in Hepatology and Gastroenterology

(2003-2006) and has worked as senior researcher in the

Group of Experimental Hepatology in the Spanish Network

for Biomedical Research on Hepatic and Digestive Diseases

(CIBERehd) since 2007 where he is now the principal

investigator He has also served on the governing board of

the Division of Hepatology and Gene Therapy in the Center

for Applied Medical Research at Pamplona and is now

Director of the Area of Digestive and Metabolic Diseases in

the Navarra Institute of Health Research

Under his collaboration or direction the Liver Unit and

the HPB Oncology Area at Cliacutenica Universidad de Navarra

have pioneered several approaches in the treatment of

liver tumours These include the use of expanded criteria to

indicate liver transplantation in patients with hepatocellular

carcinoma The close collaboration sustained for decades

with Prof Joseacute Ignacio Bilbao has resulted in relevant

contributions to the study of mechanism of action devices

procedures and indications for the intra-arterial treatment of

hepatocellular carcinoma and other primary and secondary

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

liver tumours including intra-arterial infusion chemotherapy

bland embolisation chemoembolisation and most recently

radioembolisation

The team at Cliacutenica Universitaria was the first to explore

locoregional gene therapy of liver cancer in humans by

percutaneous injection of viral vectors and developed

procedures to monitor transgene expression in vivo with

PET radiotracers In more recent years they have pioneered

the field of immunotherapy of liver cancer using different

approaches that include peptide and cell vaccination and

immune checkpoint inhibition The translational nature of

all these approaches is illustrated by the implementation of

several clinical trials exploring first-in-human and first-in-

disease applications of new agents for the treatment of liver

cancer and other liver diseases

Prof Sangro is a member of a number of national and inter-

national medical societies has served on the International

Committee of the American Society for Gene Therapy and

currently serves on the Governing Board of the International

Liver Cancer Association

Honorary Lecture

Intra-arterial treatment of hepatocellular

carcinoma at the dawn of systemic therapy

Monday April 18 1030-1130

11

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Hands-on Workshops

Image-guided tumour ablation

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of L Crocetti

This series of four stand-alone hands-on workshops will give

you the opportunity to participate in interactive sessions

targeting different organs (liver lung kidney and beyond)

In each leading interventional oncologists with many years

of experience will present cases in an informal interactive

setting allowing for questions and discussion A range of

different ablation devices (amongst others RFA cryotherapy

and microwave ablation) and some image-guidance tech-

nology will be available to the participants during the

sessions for ex-vivo demonstrations

Learning objectives

bull To learn how to handle different energy sources and the

respective equipment for tumour ablation

bull To obtain a good understanding of the range of available

ablation techniques and their proper clinical application

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal com-

bination of therapies

bull To understand the main reported complications of ablation

and the basics of preventing and managing them

bull To learn tips and tricks through the use of clinical cases

bull To learn about the indications for other medical and

surgical treatments generally

12 ECIO ndash European Conference on Interventional Oncology

C RSE

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Hands-on Workshops

Cardiovascular and Interventional Radiological Society of Europe

13

TA-HoW 1 Sunday April 17

Liver 1030-1200

Instructors AH Mahnken (MarburgDE) F Orsi (MilanIT)

M Ryan (DublinIE)

TA-HoW 2 Sunday April 17

Beyond the mainstream 1500-1630

thyroid prostate lymphnodes

Instructors JH Baek (SeoulKR) JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

TA-HoW 3 Monday April 18

Lung 1030-1200

Instructors P Kennedy (BelfastUK) CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

TA-HoW 4 Monday April 18

Kidney 1500-1630

Instructors DJ Breen (SouthamptonUK) J-M Correas (ParisFR)

CM Sommer (HeidelbergDE)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshops If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshops please refer to page 51

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

14

Supportive procedures

Co-ordinators M Bezzi (RomeIT) PL Pereira (HeilbronnDE)

Image courtesy of TK Helmberger

This hands-on workshop will give you the opportunity to

participate in interactive case presentations on supportive

therapies in cancer patients Leading interventional radio-

logists will present a number of cases in an informal inter-

active setting allowing for questions and discussion A range

of supportive devices (including devices for the management

of ascites and pleural effusion ports and central lines) will be

available to the participants during the session for ex-vivo

demonstrations

Learning objectives

bull To learn how to handle the different devices and

techniques available for supportive therapies

bull To obtain a good understanding of the range of available

techniques used to improve quality of life in patients with

advanced disease

bull To learn what factors are predictive of success and failure

in order to determine the best indication and optimal

combination of therapies

bull To learn tips and tricks through the use of clinical cases

bull To learn generally about the indications for other medical

and surgical palliative treatment options

ECIO ndash European Conference on Interventional Oncology

C RSE

NEW

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

15Hands-on Workshops

SP-HoW 1 Tuesday April 19

1030-1200

Instructors B Gebauer (BerlinDE) GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

Location

HoW Room (Liffey Meeting Room 1)

Please note that pre-registration was necessary for the hands-on

workshop If you have not pre-registered but are interested in

participating please arrive at the workshop room well in advance

to check availability

For an overview of the industry partners supporting the hands-on

workshop please refer to page 51

Cardiovascular and Interventional Radiological Society of Europe

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Special preparation courses for the EBIR

European Board of Interventional Radiology

co CIRSE

Neutorgasse 9 1010 Vienna Austria

ebircirseorg

wwwcirseorgebir

C RSE

The EBIR is a highly valuable qualification

in interventional radiology based on the

European Curriculum and Syllabus for IR

Sessions especially suited for EBIR preparation

are highlighted in the ECIO 2016 Scientific

Programme (pages 17-36)

The next EBIR examination takes place in Barcelona 9-10 September on the occasion of CIRSE 2016

Sign up to certify your expertise

European Board of Interventional Radiology

EB I R

For application deadlines and detailed information

please visit our website at wwwcirseorgebir

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Scientific Programme

SU

N

Sunday April 17

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 101 Current treatment strategies in colorectal

hepatic metastases

Moderators A Gangi (StrasbourgFR)

MJ Lee (DublinIE)

1011 From first line to maintenance

G Folprecht (DresdenDE)

1012 The rationale for resection of small liver metastases

T Gruenberger (ViennaAT)

1013 Invited scientific paper What are the factors

associated with an increased risk of local

recurrence after radiofrequency ablation or

surgical metastasectomy

N Vietti-Violi PE Bize R Duran N Demartines

N Halkic J-F Knebel A Denys LausanneCH

1014 The rationale for local ablation of small liver

metastases

PL Pereira (HeilbronnDE)

1015 The rationale of radioembolisation of colorectal

liver metastases

C Farrelly (DublinIE)

1016 Summary statement by the moderators

17

recommended for EBIR preparatione-voting

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

C RSE

SU

N

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 201 Colorectal hepatic metastases ndash clinical practice

Moderators RGH Beets-Tan (AmsterdamNL)

R Lencioni (Miami FLUS)

2011 The challenging resection ndash where IR can support

surgery

A Denys (LausanneCH)

2012 Percutaneous ablation ndash influence of device

CT Sofocleous (New York NYUS)

2013 Transarterial chemotherapy regimens

T de Baegravere (VillejuifFR)

2014 Limits of systemic therapies ndash individualised local

approaches

B George (Milwaukee WIUS)

2015 Radioembolisation in the palliative setting

R Seidensticker (MagdeburgDE)

1030-1200 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 202 Image guidance for IO

Moderators R Bale (InnsbruckAT)

L Martiacute-Bonmatiacute (ValenciaES)

2021 Ultrasound fusion imaging

L Solbiati (RozzanoIT)

2022 Cone-beam CT for vascular intervention

J-FH Geschwind (New Haven CTUS)

2023 Cone-beam CT for non-vascular intervention

MJL van Strijen (NieuwegeinNL)

2024 Combined angio and CT

PE Bize (LausanneCH)

2025 Stereotactic navigation and robotic

R Bale (InnsbruckAT)

2026 PET-CT and MRI ndash future trends

A Gangi (StrasbourgFR)

18 ECIO ndash European Conference on Interventional Oncology

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

SU

N

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 1 Image-guided tumour ablation ndash Liver

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors AH Mahnken (MarburgDE)

F Orsi (MilanIT) M Ryan (DublinIE)

1300-1430 Main Auditorium (The Liffey A)

SY 301 Satellite Symposium

For the detailed programme

please refer to page 39

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 401 Colorectal hepatic metastases

Co-ordinator JI Bilbao (PamplonaES)

Panellists L Crocetti (PisaIT) HZ Malik (LiverpoolUK)

L Martiacute-Bonmatiacute (ValenciaES) T Ruers (AmsterdamNL)

CT Sofocleous (New York NYUS)

Scientific Programme 19

recommended for EBIR preparatione-voting

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

SU

N

20 ECIO ndash European Conference on Interventional Oncology

C RSE

1500-1630 Auditorium 2 (Liffey Hall 2)

Technical Focus Session

TF 402 Recent developments

Moderators T de Baegravere (VillejuifFR)

RA Morgan (LondonUK)

4021 Drug-eluting particles ndash what can be loaded

SB White (Milwaukee WIUS)

4022 Thermal ablation ndash whats in the labs

F Orsi (MilanIT)

4023 Nanoparticles and nanodrugs ndash are we there yet

N Goldberg (JerusalemIL)

4024 Invited scientific paper Computed tomography

and magnetic resonance imaging characteristics

of novel radiopaque Yttrium-Strontium-Galliumndash

Silicate oxide glass microspheres potential materials

for radioembolisation

X Zhang S Kehoe C Davis E Tonkopi D Boyd

C Bowen R Abraham K Brewer Halifax NSCA

4025 Invited scientific paper Confocal laser endo-

microscopy for microscopic characterization of

kidney and liver tumours during ongoing in vivo

percutaneous biopsies and ex vivo cryoablation

preliminary results

A Gangi1 J Garnon1 G Tsoumakidou1 J Caudrelier1

PP Rao2 H Lang1 I Enescu1 G Koch1 V Lindner1 1StrasbourgFR 2VillejuifFR

4026 Local delivery of immunotherapy

MHMGM den Brok (NijmegenNL)

4027 Radioembolisation beyond Y-90

MGEH Lam (UtrechtNL)

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

SU

N

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 2 Image-guided tumour ablation ndash Beyond the

mainstream thyroid prostate lymphnodes

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors JH Baek (SeoulKR)

JJ Fuumltterer (NijmegenNL)

EM Walser (Galveston TXUS)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 501 Follow-up in colorectal cancer patients

are we missing something

Moderators T de Baegravere (VillejuifFR)

T Ruers (AmsterdamNL)

5011 Follow-up according to the guidelines

RGH Beets-Tan (AmsterdamNL)

5012 Do recent guidelines meet the clinical reality

PL Pereira (HeilbronnDE)

5013 Whats the key issue marker vs morphology

vs clinics

L Martiacute-Bonmatiacute (ValenciaES)

5014 Multiparametric imaging for follow-up ndash pushing

the boundaries

S Gourtsoyianni (LondonUK)

5015 Proposal for a rational follow-up regimen

R Lencioni (Miami FLUS)

21Scientific Programme

recommended for EBIR preparatione-voting

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

22 ECIO ndash European Conference on Interventional Oncology

C RSE

SU

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 502 Clinical management of the cancer patient

Moderators C Ayuso (BarcelonaES)

AG Ryan (Waterford CityIE)

5021 Who should see the patient What are the needs

for an IO practice

A Adam (LondonUK)

5022 Coagulation problems and solutions

F Niacute Aacuteinle (DublinIE)

5023 Prevention and management of infection

GA Maleux (LeuvenBE)

5024 Adjuvant interventional pain management

A Vari (RomeIT)

5025 Follow-up when and how

I Bargellini (PisaIT)

1830-1915 Main Auditorium (The Liffey A)

SY 601 Satellite Symposium

For the detailed programme

please refer to page 39

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

23

MO

N

Scientific Programme

0745-0815 Main Auditorium (The Liffey A)

SY 701 Satellite Symposium

For the detailed programme

please refer to page 41

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 801 Lung metastases

Moderators L Crocetti (PisaIT)

J Palussiegravere (BordeauxFR)

8011 Indications for local therapy ndash the oncologists view

J-E Kurtz (StrasbourgFR)

8012 Surgical resection ndash current status

M Shackcloth (LiverpoolUK)

8013 Invited scientific paper Radiofrequency abla-

tion versus surgery for the treatment of lung

metastases a comparative study

L Tselikas1 S Yevich1 T de Baegravere1 A Auperin1

O Mercier2 A Hakimeacute1 C Teriitehau1 E Fadel2

F Deschamps1 1VillejuifFR 2Plessis RobinsonFR

8014 Radiation therapy ndash current status

R Timmerman (Dallas TXUS)

8015 Percutaneous ablation ndash current status

T de Baegravere (VillejuifFR)

8016 How to evaluate the success and recurrence

after resection SBRT and ablation

RD Suh (Los Angeles CAUS)

Monday April 18

recommended for EBIR preparatione-voting

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

MO

N

24 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 802 Immunotherapy and local treatment

Moderators N Goldberg (JerusalemIL)

PL Pereira (HeilbronnDE)

8021 Immunomodulation for cancer treatment

new kid on the block

M Fuchs (MunichDE)

8022 Hepatocellular carcinoma from an immunological

perspective

BJ Wood (Bethesda MDUS)

8023 Rationale for local delivery of immunomodulating

agents and ongoing clinical trials

L Tselikas (VillejuifFR)

8024 More than just tumour destruction immunomo-

dulation via thermal ablation of cancer

C Gouttefangeas (TuebingenDE)

8025 Immunomodulation and radioembolisation

J Ricke (MagdeburgDE)

8026 Panel discussion

1030-1130 Main Auditorium (The Liffey A)

HL 901 Honorary Lecture

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

Laudation JI Bilbao (PamplonaES)

9011 Intra-arterial treatment of hepatocellular carcinoma

at the dawn of systemic therapy

B Sangro (PamplonaES)

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

1130-1200 Main Auditorium (The Liffey A)

Paper Session

PS 902 The best IO papers of 2015

Moderators A-M Belli (LondonUK)

TK Helmberger (MunichDE)

9021 Irreversible electroporation (IRE) fails to demons-

trate efficacy in a prospective multicentre phase II

trial on lung malignancies the ALICE trial

J Ricke1 JHW Juumlrgens1 F Deschamps2 L Tselikas2

K Uhde1 O Kosiek1 T de Baegravere2 1MagdeburgDE 2VillejuifFR

9022 Radiofrequency ablation inflammatory changes

in the periablative zone can induce global organ

effects including liver regeneration

N Rozenblum1 E Zeira1 B Bulvik1 S Gourevitch1

H Yotvat1 E Galun1 SN Goldberg12 1JerusalemIL 2Boston MAUS

9023 Hepatic radiofrequency ablation-induced

stimulation of distant tumour growth is suppressed

by c-Met inhibition

M Ahmed1 G Kumar1 M Moussa1 Y Wang1

N Rozenblum2 E Galun2 SN Goldberg12 1Boston MAUS 2JerusalemIL

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 3 Image-guided tumour ablation ndash Lung

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors P Kennedy (BelfastUK)

CT Sofocleous (New York NYUS)

RD Suh (Los Angeles CAUS)

1300-1345 Main Auditorium (The Liffey A)

SY 1001 Satellite Symposium

For the detailed programme

please refer to page 41

MO

N

25Scientific Programme

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

MO

N

26 ECIO ndash European Conference on Interventional Oncology

C RSE

1345-1430 Main Auditorium (The Liffey A)

SY 1002 Satellite Symposium

For the detailed programme

please refer to page 43

1500-1630 Main Auditorium (The Liffey A)

Multidisciplinary Tumour Board

MTB 1101 Lung tumours

Co-ordinator A Gillams (LondonUK)

Panellists P Kennedy (BelfastUK) J Palussiegravere

(BordeauxFR) E Quoix (StrasbourgFR) M Shackcloth

(LiverpoolUK) RD Suh (Los Angeles CAUS)

1500-1630 Auditorium 2 (Liffey Hall 2)

Joint Session

JS 1102 Meeting the diverse challenges of

interventional oncology

Joint session with the Indian Society of

Vascular and Interventional Radiology (ISVIR)

Moderators A-M Belli (LondonUK)

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11021 Current situation of interventional oncology in India

S Roy-Choudhury (KolkataIN Stoke-on-TrentUK)

11022 Thermal ablation of lung tumours

A Kulkarni (MumbaiIN)

11023 Hepatobiliary interventions in liver transplant

SS Baijal (GurgaonIN)

11024 Selective ophthalmic arterial chemoinfusion for

retinoblastoma

SS Kulkarni (MumbaiIN)

11025 Indian registry data for interventions in the

management of hepatocellular carcinoma

S Gamanagatti (New DelhiIN)

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

27

1500-1630 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

TA-HoW 4 Image-guided tumour ablation ndash Kidney

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors DJ Breen (SouthamptonUK)

J-M Correas (ParisFR) CM Sommer (HeidelbergDE)

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1201 Kidney tumours

Moderators PE Bize (LausanneCH)

A Gangi (StrasbourgFR)

12011 Renal mass ndash from surveillance to treatment

M Staehler (MunichDE)

12012 Evidence-based nephron-sparing surgery

R Power (DublinIE)

12013 Invited scientific paper Systematic review and

meta-analysis of thermal ablation versus surgical

nephrectomy for small renal tumours

KN Katsanos1 L Mailli1 ME Krokidis2 A McGrath1

T Sabharwal1 A Adam1 1LondonUK 2CambridgeUK

12014 Evidence-based ablation vs resection outcomes

DJ Breen (SouthamptonUK)

12015 Adjuvant intervention in non-resectable renal

tumours

G Carrafiello (VareseIT)

12016 Radioembolisation of renal tumours

WS Rilling (Milwaukee WIUS)

27Scientific Programme

MO

N

recommended for EBIR preparatione-voting

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

28 ECIO ndash European Conference on Interventional Oncology

C RSE

MO

N

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1202 Oncological basics

Moderators G Folprecht (DresdenDE)

LM Kenny (Brisbane QLDAU)

12021 From systemic therapy to an individualised

personalised and precision medicine

G Folprecht (DresdenDE)

12022 Phase I II III trials do you really know the

difference

S Faivre (LausanneCH)

12023 Definition of response and success in medical

oncology

OS Breathnach (DublinIE)

12024 Definition of response and success in IO

R Salem (Chicago ILUS)

12025 Best IO from ASCO

TK Helmberger (MunichDE)

12026 Panel discussion

1830-1915 Auditorium 2 (Liffey Hall 2)

SY 1301 Satellite Symposium

For the detailed programme

please refer to page 43

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

TU

E

29Scientific Programme

Tuesday April 19

0745-0815 Auditorium 2 (Liffey Hall 2)

SY 1401 Satellite Symposium

For the detailed programme

please refer to page 45

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1501 HCC ndash an update

Moderators J Lammer (ViennaAT)

B Sangro (PamplonaES)

15011 Current status of classifying HCC and tailoring

therapy ndash an update on staging

J-FH Geschwind (New Haven CTUS)

15012 Surgical perspectives on very early HCC and

early HCC

G Torzilli (MilanIT)

15013 IO perspectives on very early HCC and early HCC

C Cantwell (DublinIE)

15014 Chemoembolisation evidence for intermediate HCC

K Malagari (AthensGR)

15015 Therapies beyond BCLC guidelines

R Lencioni (Miami FLUS)

15016 Improving dosimetry in RE

E Garin (RennesFR)

recommended for EBIR preparatione-voting

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

TU

E

30 ECIO ndash European Conference on Interventional Oncology

C RSE

0830-1000 Auditorium 2 (Liffey Hall 2)

Video Learning Session

VL 1502 Lung kidney bone

Moderators DJ Breen (SouthamptonUK)

R-T Hoffmann (DresdenDE)

15021 Lung ablation

X Buy (BordeauxFR)

15022 Intra-arterial fiducial in lung tumours

PE Bize (LausanneCH)

15023 Kidney ablation

MP Fuumlrstner (KlagenfurtAT)

15024 Bone ablation

J Garnon (StrasbourgFR)

15025 Osteosynthesis

F Deschamps (VillejuifFR)

15026 Cementoplasty

DK Filippiadis (AthensGR)

1030-1200 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1601 MSK tumours

Moderators MR Callstrom (Rochester MNUS)

P Reimer (KarlsruheDE)

16011 Patient selection surgery andor IO

J-P Steib (StrasbourgFR)

16012 Can radiotherapists use the support of IR

R Timmerman (Dallas TXUS)

16013 Bone augmentation without ablation

DK Filippiadis (AthensGR)

16014 Ablative techniques for pain management

A Basile (CataniaIT)

16015 (Palliative) treatment options in soft tissue tumours

MR Callstrom (Rochester MNUS)

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

TU

E

31Scientific Programme

1030-1200 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1602 Complication management I

Moderators JI Bilbao (PamplonaES)

R Salem (Chicago ILUS)

16021 Liver thermal ablation

C Ayuso (BarcelonaES)

16022 Liver TACE

Y Arai (TokyoJP)

16023 Radioembolisation

R-T Hoffmann (DresdenDE)

16024 Bone consolidation

F Deschamps (VillejuifFR)

1030-1200 HoW Room (Liffey Meeting Room 1)

Hands-on Workshop

SP-HoW 1 Supportive procedures

Co-ordinators M Bezzi (RomeIT)

PL Pereira (HeilbronnDE)

Instructors B Gebauer (BerlinDE)

GJ Munneke (LondonUK)

KP van Lienden (AmsterdamNL)

1300-1345 Main Auditorium (The Liffey A)

SY 1701 Satellite Symposium

For the detailed programme

please refer to page 45

1345-1430 Main Auditorium (The Liffey A)

SY 1702 Satellite Symposium

For the detailed programme

please refer to page 47

recommended for EBIR preparatione-voting

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

32 ECIO ndash European Conference on Interventional Oncology

C RSE

TU

E

1500-1630 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1801 Cholangiocarcinoma

Moderators A Denys (LausanneCH)

W Jaschke (InnsbruckAT)

18011 Demographics epidemiology clinical presentation

D Gallagher (DublinIE)

18012 Surgery for central CC

O Farges (ClichyFR)

18013 Preparation for surgery ndash the IO perspective

A Denys (LausanneCH)

18014 Intraductal RFA in malignant biliary strictures

H-U Laasch (ManchesterUK)

18015 Transarterial chemotherapy

Y Arai (TokyoJP)

18016 Transarterial radioembolisation

B Peynircioglu (AnkaraTR)

1500-1630 Main Auditorium (The Liffey A)

Video Learning Session

VL 1802 Liver

Moderators I Bargellini (PisaIT)

K Malagari (AthensGR)

18021 Liver thermal ablation

L Crocetti (PisaIT)

18022 Liver chemoembolization

DW De Boo (AmsterdamNL)

18023 Liver radioembolisation

P Reimer (KarlsruheDE)

18024 Portal vein embolisation

KP van Lienden (AmsterdamNL)

18025 Hepatic vein occlusionembolisation

P Chevallier (NiceFR) B Guiu (MontpellierFR)

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

33

1700-1830 Auditorium 2 (Liffey Hall 2)

Clinical Focus Session

CF 1901 Quality assurance unnecessary bureaucracy

or essential tool

Moderators A Adam (LondonUK)

TK Helmberger (MunichDE)

19011 What is QA and why does it matter

K Ison (LondonUK)

19012 Radiation protection what it means for you

W Jaschke (InnsbruckAT)

19013 QA in surgical oncology

RA Audisio (St HelensUK)

19014 The CIRSE QA system for interventional oncology

an essential step to credibility in cancer care

LM Kenny (Brisbane QLDAU)

19015 DeGIR registry the national QA and qualification

programme (a 10-year experience)

P Reimer (KarlsruheDE)

19016 Panel discussion

TU

E

Scientific Programme

recommended for EBIR preparatione-voting

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

C RSE

34 ECIO ndash European Conference on Interventional Oncology

TU

E

1700-1830 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 1902 Complication management II

Moderators O Akhan (AnkaraTR) F Orsi (MilanIT)

19021 Lung ablation

J Palussiegravere (BordeauxFR)

19022 Kidney ablation

DJ Breen (SouthamptonUK)

19023 MSK ablation

G Tsoumakidou (StrasbourgFR)

19024 Thyroid ablation

JH Baek (SeoulKR)

1830-1900 Main Auditorium (The Liffey A)

SY 2001 Satellite Symposium

For the detailed programme

please refer to page 47

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

35

Wednesday April 20

0830-1000 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2101 The new kids on the block

Moderators J-FH Geschwind (New Haven CTUS)

BJ Wood (Bethesda MDUS)

21011 IRE technique current status and developments

N Goldberg (JerusalemIL)

21012 HIFU technique current status and developments

I Mindjuk (DachauDE)

21013 Invited scientific paper

21014 Clinical status of HIFU

F Orsi (MilanIT)

21015 New devices for biopsy

J-Y Gaubert (MarseilleFR)

21016 Comparison of the different drug-eluting bead

platforms

J Namur (Jouy en JosasFR)

1000-1045 Main Auditorium (The Liffey A)

SY 2102 Satellite Symposium

For the detailed programme

please refer to page 49

WE

D

Scientific Programme

recommended for EBIR preparatione-voting

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

36 ECIO ndash European Conference on Interventional Oncology

WE

D

1115-1245 Main Auditorium (The Liffey A)

Clinical Focus Session

CF 2201 Neuroendocrine tumours

Moderators DJ Breen (SouthamptonUK)

B Gebauer (BerlinDE)

22011 Demographics epidemiology clinical presentation

M Eatock (BelfastUK)

22012 Systemic therapy

M Pavel (BerlinDE)

22013 Invited scientific paper Simultaneous (18)F-FDOPA

PETCT-guided biopsy and radiofrequency ablation

of recurrent neuroendocrine hepatic metastasis

further step toward a theranostic approach

A Imperiale J Garnon P Bachellier A Gangi

IJ Namer StrasbourgFR

22014 Nuclear medicine ndash diagnostics and treatment

F Forrer (St GallenCH)

22015 Transarterial therapy ndash chemoembolisation and

bland embolisation

B Guiu (MontpellierFR)

22016 Transarterial therapy ndash radioembolisation

JI Bilbao (PamplonaES)

C RSE

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

37

Cardiovascular and Interventional Radiological Society of EuropeC RSE

Seventh European Conference

on Interventional Oncology

April 17-20 2016

Dublin Ireland

ECIO 2016

Cardiovascular and Interventional Radiological Society of Europe

LEADERS IN ONCOLOGICINTERVENTIONS

CORPORATE ACTIVITIES amp EXHIBITION

Satellite Symposia

Hands-on Workshop Sponsors

Technical Exhibition

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

38 ECIO ndash European Conference on Interventional Oncology

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

39

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1300-1430 Main Auditorium (The Liffey A)

BTG

SY 301 See more Reach further Treat smarter

Individualising treatment in interventional

oncology

Moderators A Denys (LausanneCH)

TF Jakobs (MunichDE)

3011 Dosimetry from the clinical perspective why it

matters and how it works with TheraSpherereg

R Salem (Chicago ILUS)

3012 90Y microspheres dosimetry made simple

MGEH Lam (UtrechtNL)

3013 The evolution of TACE does novel technology mean

better outcomes

R Lencioni (Miami FLUS)

1830-1915 Main Auditorium (The Liffey A)

Boston Scientific

SY 601 Clinical updates and new insights on TANDEMTM

Microspheres in the treatment of HCC and mCRC

Moderators P Kennedy (BelfastUK)

GM Richter (StuttgartDE)

6011 Advanced and intensified microparticle chemo-

embolisation in liver tumours with curative potential

ndash breaking data from Miracle 1 trial

GM Richter (StuttgartDE)

6012 TANDEMTM loaded with Doxorubicin in the treatment

of HCC ndash pharmacokinetics and clinical results

K Malagari (AthensGR)

6013 Clinical results of a single center trial with Irinotecan

loaded TANDEMTM Microspheres in patients with

mCRC ndash the importance of optimal embolisation

technique

F Orsi (MilanIT)

Sunday April 17

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

40 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

41

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Main Auditorium (The Liffey A)

Toshiba Medical Systems Europe

SY 701 Innovating clinical pathways

Moderator B Guiu (MontpellierFR)

7011 New frontiers for interventional radiology under

ultrasound guidance combination of smart fusion

and smart navigation solutions

J Garnon (StrasbourgFR)

7012 INFINIX 4D CT Singapore General Hospital

experience

KH Tay (SingaporeSG)

1300-1345 Main Auditorium (The Liffey A)

Terumo Europe

SY 1001 IO armamentarium in the treatment algorithm

of mCRC

Moderators D Arnold (FreiburgDE)

PL Pereira (HeilbronnDE)

10011 Role of interventional oncology in CRC

ESMO guidelines

D Arnold (FreiburgDE)

10012 Case presentation

D Arnold (FreiburgDE)

10013 Intra-arterial infusion therapy D

T de Baegravere (VillejuifFR)

10014 Transarterial radioembolisation

A Denys (LausanneCH)

10015 DEB-TACE

PL Pereira (HeilbronnDE)

10016 Discussion

Conclusion and take home message

Monday April 18

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

42 ECIO ndash European Conference on Interventional Oncology

C RSE

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

43

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Medtronic

SY 1002 Innovations in thermal ablation

Moderator A Gillams (LondonUK)

10021 More than 1 year follow-up with Thermosphere

technology

T de Baegravere (VillejuifFR)

10022 Experiences of Thermosphere technology in renal

tumour ablation

A Magnusson (UppsalaSE)

10023 Liver complex cases with Thermosphere

technology

P Wiggermann (RegensburgDE)

1830-1915 Auditorium 2 (Liffey Hall 2)

Cocktail reception to be served in the room

Sirtex Medical Europe GmbH

SY 1301 Multi-modality treatment of colorectal liver

metastases (CLM) in 2016

Moderators TK Helmberger (MunichDE)

B Sangro (PamplonaES)

13011 The importance of the liver in metastatic

colorectal cancer (mCRC)

B Sangro (PamplonaES)

13012 Chemotherapy in mCRC

O Dubreuil (ParisFR)

13013 Loco-regional therapies for colorectal liver

metastases (CLM)

TK Helmberger (MunichDE)

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

44 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

45

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

0745-0815 Auditorium 2 (Liffey Hall 2)

PharmaCept GmbH

SY 1401 Studies based on DSM-TACE (EmboCeptreg S)

Moderator TJ Vogl (FrankfurtDE)

14011 DSM-TACE multicentre study in HCC treatment

placed in the Triveneto area northeastern Italy

S Dal Bello (Castelfranco VenetoIT)

14012 Introduction of the study concept FAST I ndash IV

TJ Vogl (FrankfurtDE)

1300-1345 Main Auditorium (The Liffey A)

Sirtex Medical Europe GmbH

SY 1701 Optimising the treatment of colorectal

liver metastases (CLM) with SIR-Spheresreg Y-90

resin microspheres

Moderators JI Bilbao (PamplonaES)

T de Baegravere (VillejuifFR)

17011 SIRFLOX study results

V Heinemann (MunichDE)

17012 Who are the best patients for SIR-Spheres Y-90

resin microspheres in CLM

P Boardman (OxfordUK)

17013 Panel discussion

Tuesday April 19

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

46 ECIO ndash European Conference on Interventional Oncology

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

47Satellite Symposia

1345-1430 Main Auditorium (The Liffey A)

Guerbet

SY 1702 cTACE principles clinical data amp guidelines

across the world

Moderator J-FH Geschwind (New Haven CTUS)

17021 cTACE fundamentals amp mechanism of action

J-FH Geschwind (New Haven CTUS)

17022 Unrivalled clinical data from Hepatology 2002

to Hepatology 2016

R Lencioni (Miami FLUS)

17023 Role of cTACE in guidelines of management of HCC

across the world

JM Llovet (BarcelonaES)

1830-1900 Main Auditorium (The Liffey A)

Merit Medical

SY 2001 Management of complex anatomy with

SwiftNINJAreg steerable microcatheter

Moderator Y Arai (TokyoJP)

20011 What is NINJA

Y Arai (TokyoJP)

20012 Initial experience with the SwiftNINJAreg in a high

volume interventional oncology centre

BC Meyer (HannoverDE)

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

48 ECIO ndash European Conference on Interventional Oncology

C RSE

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

49

Cardiovascular and Interventional Radiological Society of Europe

Satellite Symposia

1000-1045 Main Auditorium (The Liffey A)

Siemens Healthcare GmbH

SY 2102 Treatment efficacy and intra-procedural

therapy verification

21021 Flat-detector CT blood volume imaging in TACE

for HCC implications for treatment planning and

response

RL ODonohoe (DublinIE)

21022 Image-guided vertebroplasty with MIYABI

Angio-CT

F Clarenccedilon (ParisFR)

Wednesday April 20

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Hands-on Workshop Sponsors 51

The Image-guided tumour ablation hands-on workshop

is kindly supported by

bull AngioDynamics

bull Clinical Laserthermia Systems AB

bull Galil Medical

bull GE Healthcare

bull Medtronic

bull NeuWave Medical

bull Olympus Surgical Technologies Europe

bull RF Medical Co Ltd

bull Terumo Europe

The Supportive procedures hands-on workshop is kindly

supported by

bull Cook Medical

For detailed information on the hands-on workshops

please refer to pages 12-15

For further information about the industry partners please

refer to the Technical Exhibitors Guide (pages 61-83)

If you are interested in obtaining product information

outside of the hands-on workshop sessions please visit the

respective company booth in the exhibition area

Hands-on Workshop Sponsors

Cardiovascular and Interventional Radiological Society of Europe

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

52 ECIO ndash European Conference on Interventional Oncology

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

53

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Diamond Sponsors

54

DIAMOND

Booth 1

Booth 12

Booth 9

Booth 24

Booth 11

Booth 10

C RSE

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Platinum Sponsor

Boston Scientific International Booth 2

Gold Sponsors

Merit Medical Booth 22

PharmaCept Booth 18

STARmed Booth 4

Toshiba Medical Systems Europe Booth 23

Silver Sponsors

Clinical Laserthermia Systems Booth 13

DFINE Europe Booth 3

Galil Medical Booth 16

GE Healthcare Booth 8

NeuWave Medical Booth 17

RF Medical Booth 21

Surgical Specialties Booth 14

SILVERGOLD

PLATINUM

55

Platinum | Gold | Silver Sponsors

Cardiovascular and Interventional Radiological Society of Europe

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

56 ECIO ndash European Conference on Interventional Oncology

C RSE

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

Boston Scientific International 2

BTG 1

Clinical Laserthermia Systems 13

Delcath Systems 19

DFINE Europe 3

Endocare 6

Galil Medical 16

GE Healthcare 8

Guerbet 12

Hyprevention PTIB 7

Interventional News BIBA 4a

Medtronic 9

Merit Medical 22

Mint Medical 4b

Nanjing ECO Microwave System 20

NeuWave Medical 17

NUMA 15

PharmaCept 18

RF Medical 21

Siemens Healthcare 24

Sirtex Medical Europe 11

STARmed 4

Surefire Medical 5

Surgical Specialties 14

Terumo Europe 10

Toshiba Medical Systems Europe 23

Wisepress Medical Bookshop 25

Technical Exhibition (Alphabetical List)

57

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibition

Official Name Booth

BTG 1

Boston Scientific International 2

DFINE Europe 3

STARmed 4

Interventional News BIBA 4a

Mint Medical 4b

Surefire Medical 5

Endocare 6

Hyprevention PTIB 7

GE Healthcare 8

Medtronic 9

Terumo Europe 10

Sirtex Medical Europe 11

Guerbet 12

Clinical Laserthermia Systems 13

Surgical Specialties 14

NUMA 15

Galil Medical 16

NeuWave Medical 17

PharmaCept 18

Delcath Systems 19

Nanjing ECO Microwave System 20

RF Medical 21

Merit Medical 22

Toshiba Medical Systems Europe 23

Siemens Healthcare 24

Wisepress Medical Bookshop 25

Technical Exhibition (Numerical List)

59

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

C RSE

ECIO ndash European Conference on Interventional Oncology60

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

Technical Exhibitors Guide 61

Boston Scientific International SA 2

2 rue Reneacute Caudron CS 30206

78961 St Quentin en Yvelines CEDEX

FRANCE

Phone +33 139 30 97 00

wwwbostonscientificcom

Boston Scientific (NYSE BSX) is a worldwide developer manu-

facturer and marketer of medical devices with approximately

23000 employees and revenue of $7380 billion in 2014

Boston Scientific transforms lives through innovative medical

solutions that improve the health of patients around the

world As a global medical technology leader for more than 30

years we advance science for life by providing a broad range

of high performance solutions that address unmet patient

needs and reduce the cost of healthcare For more informa-

tion visit wwwbostonscientificeu and connect on Twitter

(bostonsci) and Facebook

BTG 1

Lakeview Riverside Way

Watchmoor Park Camberley

GU15 3YL Surrey

UNITED KINGDOM

Phone +44 1276 902 020

Fax +44 1252 732 777

wwwbtgplccom

At BTG we are focused on bringing to market innovative

pro ducts in specialist areas of medicine to better serve

doctors and patients Our growing portfolio of Interventional

Medicine products is designed to advance the treatment of

liver tumours advanced emphysema severe blood clots and

varicose veins while our Specialty Pharmaceuticals portfolio

offers antidotes that alleviate toxicity and treat rare con-

ditions Our products are primarily used in the treatment

of people with liver tumours and other hypervascularised

tumours as well as arteriovenous malformation The bead

products block arteries (embolisation) depriving tumours of

blood and nutrients Where approved drug-eluting beads

also deliver a chemotherapeutic drug directly to the tumour

Our radiotherapy product consists of millions of small glass

microspheres that deliver radiation directly to liver tumours

Technical Exhibitors Guide

PLATINUM

DIAMOND

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

62 ECIO ndash European Conference on Interventional Oncology

C RSE

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

63Technical Exhibitors Guide

Clincal Laserthermia Systems 13

Medicon Village Scheelevaumlgen 2

223 81 Lund

SWEDEN

Phone +46 46 15 21 00

wwwclinicallaserse

Clinical Laserthermia Systems (CLS) is a research-based

pro duct company which has developed the CE-marked

FDA-approved medical device TRANBERGCLS Cancer

Immunotherapy System and the imILTCLS treatment method

The product is fully developed and approved for use in

Europe and US to treat solid cancer tumors The equipment

consists of a mobile laser unit and sterile disposable patient

kits Primary tumors for which treatment with imILTCLS is

indicated may be found in the liver breast skin (malignant

melanoma) lung prostate kidney and pancreas The cancer is

treated with the heat produced by laser light which is guided

into the tumor via an optical fiber The system measures

and guides the heat in the tumor growth areas and causes

controlled local cell death The heat stimulates an immune-

mediated anti-cancer effect a kind of vaccination against

the treated cancer type Treatment can be provided as a minor

poly clinical procedure where the patient may be discharged

from the hospital after a brief period of observation imILTCLS

can be combined with immunostimulating drugs immediately

before during or after treatment During 2014-2016 CLS

is carrying out clinical studies in Europe CLS is based in

Medicon Village Lund Sweden

Delcath Systems 19

Unit 19 Mervue Business Park

Mervue Galway

IRELAND

Phone +353 91 746200

wwwchemosatcom

Delcath Systems is a specialty pharmaceutical and medical

device company focused on oncology Our proprietary

product ndash the Delcath Hepatic Delivery System for use with

Melphalan Hydrochloride ndash is designed to administer high-

dose chemotherapy to the liver while controlling systemic

exposure

SILVER

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

64 ECIO ndash European Conference on Interventional Oncology

C RSE

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

65Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

SILVERDFINE Europe GmbH 3

Dynamostr 3

68165 Mannheim

GERMANY

Phone +49 621 8209 00

Fax +49 621 820 905 77

E-Mail infodfineeu

wwwdfineeu

DFINE is a medical device company dedicated to improving

patient quality of life through the development of inno-

vative minimally invasive therapeutic devices used to

treat pathologies of the vertebrae DFINE is the developer

of Radiofrequency-Targeted Vertebral Augmentationtrade

(RF-TVAtrade) also referred to as RF Kyphoplasty a novel

approach to stabilizing vertebral compression fractures

relieving pain and improving patient mobility Performed

with the companys flagship StabiliTreg Vertebral Augmen-

tation System RF -TVAtrade provides physicians with greater

control in the treatment of vertebral compression fractures

through site- and size-specific cavity creation ultra-high

viscosity bone cement with extended working time and a

unique remotely controlled cement delivery system

DFINE recently received 510(k) clearance for the STARtrade

Tumor Ablation System a new product line designed for the

palliative treatment of cancer patients The product provides

minimally invasive localized tumor ablation for symptomatic

spinal metastases offering patients the potential for

significant and immediate pain relief DFINE Europe GmbH is

based in Mannheim Germany

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

66 ECIO ndash European Conference on Interventional Oncology

C RSE

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

67Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Endocare Inc 6

9825 Spectrum Drive Building 3

TX 78717 Austin

UNITED STATES

Phone +1 512 314 4391

E-Mail internationalhealthtronicscom

wwwhealthtronicscom

Endocare Inc is a medical device company focused on the

development of minimally invasive technologies for tissue

and tumor ablation With over 10 years of clinical experience

in percutaneous cryoablation for kidney lung palliative pain

management and other tissues we remain committed to

innovative technology that improves and extends patientsrsquo

lives

Galil Medical 16

4364 Round Lake Road West

MN 55112 Arden Hills

UNITED STATES

Phone +1 877 639 2796

Fax +1 877 510 7757

E-Mail infogalilmedicalcom

wwwgalilmedicalcom

Galil Medical develops manufactures and distributes inno-

vative cryoablation systems and disposable products for

minimally invasive tissue ablation Galil Medical is the only

company solely committed to advancing cryoablation over

a broad range of applications demonstrated by product

and technology innovation physician collaboration new

product introductions and multiple ongoing clinical studies

Stop by the Galil Medical booth to share your insight on

ablative applications and to learn about resources available

to support your interventional oncology practice Galil

Medical is based in Arden Hills Minnesota with operations in

Yokneam Israel

SILVER

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

68 ECIO ndash European Conference on Interventional Oncology

GE Healthcare 8

283 rue de la Miniegravere

78530 Buc

FRANCE

Phone +33 6 28 03 12 71

E-Mail jocelynkartesgecom

wwwgehealthcarecouk

GE Healthcare provides transformational medical technolo-

gies and services to meet the demand for increased access

enhanced quality and more affordable healthcare around

the world GE (NYSE GE) works on things that matter ndash great

people and technologies taking on tough challenges From

medical imaging software amp IT patient monitoring and dia-

gnostics to drug discovery biopharmaceutical manufacturing

technologies and performance improvement solutions GE

Healthcare helps medical professionals deliver great health-

care to their patients For more information visit our website

wwwgehealthcarecouk

Guerbet 12

PO Box 57400

95943 Roissy CdG Cedex

FRANCE

Phone +33 1 45 91 50 00

E-Mail directioncommunicationguerbet-groupcom

wwwguerbetcom

Guerbet is a human-scale company that aims to become

a new global leader in medical imaging A pioneer in con-

trast media with 90 years of experience Guerbet is the

only pharmaceutical group dedicated to medical imaging

worldwide with a presence in almost 80 countries via a

network of subsidiaries and distributors The company offers

a comprehensive range of CT scan Cath Lab Magnetic

Resonance Imaging (MRI) and Interventional Radiology

and Theranostics (IRT) products along with a range of in-

jectors and related medical devices to improve patients

diagnosis prognosis and quality of life More than 60000

health professionals rely on Guerbets contrast agents

Advancing in innovation solutions the diagnosis of major

diseases (cardiovascular diseases cancers diseases of the

central nervous system) and interventional radiology while

SILVER

DIAMOND

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

69Technical Exhibitors Guide

reconciling efficacy and cost containment are at the heart

of Guerbets mission Since the acquisition of Mallinckrodts

Contrast Media and Delivery Systems activity its total

workforce is 2500 employees Achieve Cooperate Care

and Innovate are the values that Guerbets employees share

and practice every day Working at Guerbet means playing

a unique part in the future of medical imaging Passionate

about its business the company strives day in day out to

combine performance quality and sustainable development

Hyprevention 7

PTIB ndash Hopital Xavier Arnozan

Avenue du Haut-Leveque

33604 Pessac

FRANCE

wwwhypreventioncom

Founded in 2010 by Ceacutecile Vienney (CEO) and 3 orthopedic

surgeons Hyprevention is a French company that develops

manufactures and sells implantable medical devices to

address unmet clinical needs It is certified ISO 13485

2003 since January 2014 and CMDCAS since January 2015

Hyprevention received CE mark approval for its first product

Y-STRUTreg indicated for percutaneous internal fixation for

impending pathological fracture of proximal femur

Interventional News 4a

526 Fulham Road

SW6 5NR London

UNITED KINGDOM

Phone +44 20 7736 8788

Fax +44 20 7736 8283

E-Mail shilpabibamedicalcom

wwwinterventionalnewscom

Interventional News is a specialised quarterly newspa-

per which goes out to over 12100 subscribers in Europe

and North America Published by BIBA Medical it is an

editorially independent news brand steered by internation-

ally renowned editors-in-chief Professor Andy Adam and

Cardiovascular and Interventional Radiological Society of Europe

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

70 ECIO ndash European Conference on Interventional Oncology

Dr Brian Stainken Interventional News contains the latest

news opinion from thought leaders in interventional radio-

logy summaries of cutting-edge research expert analysis

conference coverage information and updates on the latest

products and the medical device industry Please visit

wwwinterventionalnewscom for regular breaking news

updates and download the IN app for Apple devices from the

app store for live conference coverage Stay in touch with the

latest developments in the world of intervention ndash get your

free subscription to the print copy of Interventional News and

our fortnightly e-newsletters at httpwwwcxvascularcom

publishing-orders

Medtronic 9

Victor Von Bruns-Strasse 19

8212 Neuhausen Am Rheinfall

SWITZERLAND

wwwmedtroniccom

As a global leader in medical technology services and

solutions Medtronic improves the health and lives of millions

of people each year We believe our deep clinical therapeu-

tic and economic expertise can help address the complex

challenges ndash such as rising costs aging populations and the

burden of chronic disease ndash faced by families and health-

care systems today But no one can do it alone Thatrsquos why

wersquore committed to partnering in new ways and developing

powerful solutions that deliver better patient outcomes

Founded in 1949 as a medical repair company were now

among the worlds largest medical technology services and

solutions companies employing more than 85000 people

worldwide serving physicians hospitals and patients in more

than 155 countries Join us in our commitment to take health-

care Further Together Learn more at Medtroniccom

C RSE

DIAMOND

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

71Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Merit Medical 22

Amerikalaan 42

6199 AE Maastricht

NETHERLANDS

E-Mail marketingemeameritcom

wwwmeritemeacom

Merit Medical is a worldwide company engaged in the de-

velopment manufacture and distribution of medical devices

used in interventional oncology procedures Meritrsquos com-

prehensive product portfolio allows you to access diagnose

and treat tumors This portfolio includes radial access pro-

ducts the SwiftNINJAreg steerable microcatheter for delivery

of embolics and the Safeguardtrade closure device In addition

Merit offers the HepaSpheretrade Microspheres embolic (not

available in the United States) which is indicated for emboli-

zation of hepatocellular carcinoma and for liver metastases

HepaSpheretrade Microspheres embolic can be loaded with

Doxorubicin or Irinotecan and is conformable for optimal

occlusion and contact with the vessel wall resulting in need-

ing fewer vials

Mint Medical 4b

Friedrich-Ebert-Straszlige 2

69221 DossenheimHeidelberg

GERMANY

Phone +49 6221 6479 76-1

Fax +49 6221 6479 76-8

E-Mail infomint-medicalde

wwwmint-medicalcom

Mint Medical provides software solutions for standardized

context-driven read procedures and structured reports for

oncologic disease in clinical routine and research

Developed and adapted to the daily needs of oncologic

radio logy Mint Medicalrsquos software solution mint Lesiontrade

focuses on the particular context of a patient case and gen-

tly offers guidance according to the corresponding scree-

ning staging or response assessment criteria mint Lesiontrade

knows about the intricacies of particular guidelines and

GOLD

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

72 ECIO ndash European Conference on Interventional Oncology

C RSE

automatically determines the stage of disease and response

to therapy based on radiological multiparametric image

annotations classifications and further clinical parameters

The profiles include a variety of TNM tumor entities staging

and transplant scoring of liver disease screening and staging

of prostate carcinoma and numerous response evaluation

criteria (RECIST mRECIST HCC Cheson irRC irRECIST Choi

RANO PCWG2 etc) In addition mint Lesiontrade characterizes

lesions also by their texture and highlights potential tipping

points for clinical treatment decisions during the read process

and in the automatically generated structured reports

Nanjing ECO Microwave System Co Ltd 20

10F 2nd Building Binjiang Plaza No305

North Jiangdong Rd

Nanjing

CHINA

Phone +86 25 86587596

Fax +86 25 86262777

wwwnjecomedcom

We are a manufacturer in China focused on interventional

oncology We have 14 years of experience with cancer treat-

ment (MWA) since the year 2002 We have also invented the

Water Circulation Cooling System and make MWA and even

RFA treatments available for most patients Now we have

more than 400 MWA installations worldwide including port-

able systems and mobile systems The top model is equipped

with LCD touch-screen self-check function and temperature

monitoring function This will help to make treatments safer

and more effective The application for MWA has been ex-

tended to liver cancer lung cancer thyroid nodules breast

nodules and cancer uterine fibroids bone tumors and kidney

tumors Our antenna can be guided under ultrasound and

CT scan and is also MRI compatible We also hold the China

International Conference for Microwave Tumor Ablation

Treatment each year at Dec 12th in Nanjing China Last

year 400 doctors attended this conference where the latest

research on MWA treatment was shared with visitors

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

73Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

NeuWave Medical 17

3529 Anderson St

WI 53704 Madison

UNITED STATES

Phone +1 877 323 9283

Fax +1 608 512 1509

E-Mail infoneuwavecom

wwwneuwavecom

NeuWave Medicalreg Inc founded by physicians and scientists

created the first Intelligent Ablationtrade system powered by

the Certusreg 140 The unique auto-synchronized system offers

predictable round ablations for any shape or size lesion With

a focus on predictability and simple versatility this total treat-

ment platform provides a truly scalable system that delivers

tailored treatment for patients

NUMA 15

Block 1 Quayside Business Park Mill Street Dundalk

A91 DP8R Co Louth

IRELAND

Phone +353 42 9429502

Fax +353 42 9390220

E-Mail infonumaie

wwwnumaie

Image-guided Minimally Invasive Cancer Treatments (MICTs)

form a rapidly growing field of alternatives to full surgical

resection allowing an interventionalist to perform highly

targeted treatments Prediction of the precise ablation

boundary is crucial to ensure both complete tumour

destruction and the protection of sensitive structures To

assist radiologists in the training and planning for these

interventions two software tools have been developed by

the Go-Smart (wwwgosmart-projecteu) and ClinicIMPPACT

(wwwclinicimppacteu) projects co-funded by the European

Commissionrsquos FP7 programme The GoSmart software pro-

vides a unified web environment enabling interventionalists

to upload patient scans identify important structures and

SILVER

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

74 ECIO ndash European Conference on Interventional Oncology

C RSE

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

75Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

simulate a range of key MICTs It is highly extensible with

an interface for manufacturers researchers and medical

tech nicians to incorporate new equipment treatment

protocols and theoretical models The RFA-Guardian software

developed in the ClinicIMPPACT project provides a very fast

Radio Frequency Ablation (RFA) simulation environment

that is currently based around the AngioDynamics StarBurst

XL needle and is part of a clinical trial in 4 hospitals across

Europe Its speed and optimised functionality for clinical use

make it very attractive for RFA planning

PharmaCept GmbH 18

Bessemerstraszlige 82

12103 Berlin

GERMANY

Phone +49 30 75 65 985-0

E-Mail infopharmaceptcom

wwwpharmaceptcom

PharmaCept stands for a successful development of niche

products and instructions in the area of cancer treatment

with a special focus on research in Interventional Oncology

The main pillar of our companyrsquos development is in the field

of chemoembolization therapy On the basis of the Barcelona

guidelines for the treatment of primary liver cell carcinoma

chemoembolization has become an integral part of the treat-

ment of this illness Increasing experience has shown that

the use of permanent vascular occlusion materials promotes

the development of new blood vessels which sustain tumor

growth As well as stimulating growth permanent vascular

occlusion also exacerbates pain With EmboCeptreg S our bio-

degradable starch microspheres these side effects can be

considerably reduced New clinical studies will now further

scientifically explore the already known advantages of short-

term vessel-blockage and unlimited combination with drugs

eg our Cisplatin powder named PlatiCeptreg with the use of

our embolizate EmboCeptreg S

GOLD

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

76

C RSE

ECIO ndash European Conference on Interventional Oncology

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

RF Medical Co Ltd 21

503 506 254 Beotkkot-ro

Geumcheon-gu

153-801 Seoul

KOREA

E-Mail overseasrfacokr

wwwrfacokr

As a manufacturer RF Medical is dedicated to popularizing

radiofrequency ablation treatments since 2003 Our extensive

product range spans from tumor ablation to varicose vein

treatments Our sophisticated technology has allowed us

to spread our business to more than 40 countries and our

proven quality has granted us a strong reputation on the

market As always RF Medical strives with all its capabilities

to create a healthier world by continuous investment in

research and development

Siemens Healthcare GmbH 24

Henkestr 127

91052 Erlangen

GERMANY

Phone +49 9131 84-0

Fax +49 9131 84-2924

E-Mail contacthealthcaresiemenscom

wwwhealthcaresiemenscom

Siemens Healthcare is one of the worldrsquos largest suppliers

of technology to the healthcare industry and a leader in

medical imaging laboratory diagnostics and healthcare

IT All supported by a comprehensive portfolio of clinical

consulting training and services available across the globe

and tailored to customersrsquo needs

In fiscal 2014 Siemens Healthcare had around 43000

em ployees worldwide and posted a revenue worth

117 billion euros and profits of more than 2 billion euros

Further information is available on the Internet at

httpwwwhealthcaresiemenscom

SILVER

77Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

DIAMOND

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

78 ECIO ndash European Conference on Interventional Oncology

C RSE

Sirtex Medical Europe GmbH 11

Joseph-Schumpeter-Allee 33

53227 Bonn

GERMANY

Phone +49 228 18407 30

Fax +49 228 18407 35

E-Mail infosirtex-europecom

wwwsirtexcom

Sirtex Medical is actively engaged in the field of liver-directed

therapies for cancer patients The innovative technology of

Sirtex SIR-Spheresreg Y-90 resin microspheres (microscopic

Yttrium-90 resin beads) is a medical device used in inter-

ventional oncology to deliver Selective Internal Radiation

Therapy (SIRT) also known as radioembolisation to the liver

This treatment for inoperable liver cancer delivers high doses

of radiation directly to the site of tumours whilst conserving

normal liver parenchyma SIR-Spheresreg microspheres were

approved in 2002 for use in the treatment of a variety of

unresectable liver tumours as well as in hepatocellular carci-

noma within the European Union under a CE Mark They are

presently used at 250+ institutions in Europe and over 55000

doses of SIR-Spheresreg microspheres have been supplied

worldwide

The SIRFLOX study evaluated the efficacy and safety of add-

ing SIR-Spheresreg Y-90 resin microspheres to a current first-

line systemic chemotherapy in patients with non-resectable

colorectal liver metastases SIRFLOX is the largest randomised

interventional radiology study ever conducted in oncology

This study has now been published in the Journal of Clinical

Oncology the most widely read prestigious official journal of

the ASCO

DIAMOND

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

79

Cardiovascular and Interventional Radiological Society of Europe

Technical Exhibitors Guide

STARmed Co Ltd 4

402 Daebang Triplaon B 1681

Jungsan-dong IlsanDong-gu

410315 Goyang-si Gyeonggi-do

KOREA

Phone +82 506 816

E-Mail infostarmed4ucom

wwwstarmed4ucom

STARmed Co Ltd is a young and fast-growing company

from South Korea specializing in radiofrequency tech nology

Passionately working on the best possible RF treatment

STARmed has collaborated with a number of key opinion

leaders in developing the most innovative electrodes and

leading-edge RF technology specific to certain tumour types

and clinical applications in liver lung kidney myoma bone

etc Currently STARmed is proud to be the world leader in

thermal ablation of benign thyroid nodules through radio-

frequency In addition to RampD and manufacturing STARmed

devotes its time and resources to professional education

through master classes hands-on workshops and proctor-

ship for doctors keen on such minimally invasive procedures

STARmed strives to be your best partner in radiofrequency

ablation

Surefire Medical Inc 5

6272 W 91st Avenue

CO 80031 Westminster

UNITED STATES

Phone +1 303 426 1222

Fax +1 303 426 1223

E-Mail infosurefiremedicalcom

wwwsurefiremedicalcom

Surefire Medical Inc based in Westminster Colo was

founded in 2009 to develop innovative infusion systems for

the Interventional Radiology and the Interventional Oncology

markets Surefirersquos technology is designed to precisely deliver

embolic agents through a unique microcatheter with an

expandable tip which collapses during forward flow to allow

normal blood flow to carry therapy as close to the tumor

GOLD

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

80 ECIO ndash European Conference on Interventional Oncology

C RSE

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

81Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

as possible In reverse flow when drugsmicrospheres are

being delivered by the system the tip automatically and

dynamically expands to the vessel wall creating a pressure

gradient that drives the therapeutic agents deeply into the

tumor while blocking backflow that might damage healthy

tissue The Surefire Infusion Systems and Surefire Precision

have received regulatory approval in the US Europe

Canada Australia New Zealand Taiwan Mexico and Brazil

Surgical Specialties Corporation 14

50 Braintree Hill Office Park Suite 101

MA 02184 Braintree

UNITED STATES

Phone +1 781 602 6771

wwwsurgicalspecialtiescom

Surgical Specialities designs and manufactures high per-

formance interventional radiology products surgical knives

and wound closure products At ECIO we are featuring the

BioSentrytrade Tract Sealant System a CE and FDA-approved

device to help prevent Pneumothorax BioSentry is a repeat-

able straight-forward two minute procedure used after a

lung biopsy which has proven protection in clinical trials to

reduce pneumothorax by 50 and chest tube placement

by 67 Please stop by our booth 14 to learn more and

request a demo Surgical Specialties Corporation is a sharp

company driven by sharp dedicated people It has a proven

track record within the field of precision surgical instrument

design and manufacturing that underscores not only its

high engineering standards but also its customer-driven

collaborative values Surgical Specialties Corporation is proud

to provide quality products flexible and accommodating

customer service and value to its customers worldwide

Zaetta JM Licht MO Fisher JS Avelar RL Bio-Seal Study Group A lung

biopsy tract plug for reduction of postbiopsy pneumothorax and

other complications results of a prospective multicenter randomized

controlled clinical study J Vasc Interv Radiol 2010211235-1243

SILVER

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

ECIO ndash European Conference on Interventional Oncology

Terumo Europe 10

7-9 Rue Eugegravene et Armand Peugeot

92500 Rueil Malmaison

FRANCE

Phone +33 1 47 16 09 46

Fax +33 1 47 16 09 49

E-Mail alexandravassiliadesterumo-europecom

wwwterumo-europecom

Founded in Tokyo in 1921 Terumo is a multinational company

with more than 90 yearsrsquo experience in developing best in

class medical devices Pushing boundaries is what drives us

so that interventionalists can do more Rising to the challenge

of innovating for patients Terumo brings you a complete

range of Interventional Oncology products

Leading edge access and delivery systems (Occlusafereg

Radiofocusreg Guidewire GT Progreatreg Glidecathreg)

Complete range of embolic devices (AZURreg Peripheral

HydroCoilreg AZURreg CX HydroPearlreg)

Ablation systems (MicroThermXreg)

Easily visible Radioembolics (manufactured by Quirem)

Drug-eluting Microspheres (LifePearlreg)

Having pioneered the field of Interventional Oncology

Terumo is relentlessly seeking new ways to help you apply

effective solutions and achieve better outcomes We are

committed to support our comprehensive product portfolio

by a well-trained field force and a solid clinical evidence

DIAMOND

C RSE

82

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

83Technical Exhibitors Guide

Cardiovascular and Interventional Radiological Society of Europe

Toshiba Medical Systems Europe 23

Zilverstraat 1

2718RP Zoetermeer

NETHERLANDS

Phone +31 79 3689 222

wwwtoshiba-medicaleu

For over 140 years Toshibarsquos research and development has

improved the health and welfare of people around the world

Today Toshiba Medical Systems offers a full range of dia-

gnostic imaging products and is a reliable service partner

in more than 135 countries around the globe Our Mission is

to deliver the best quality products and services as well as

the industryrsquos best after-sales support through long-term

customer focused partnerships

Wisepress Medical Bookshop 25

25 High Path

Merton Abbey

SW19 2JL London

UNITED KINGDOM

Phone +44 20 8715 1812

Fax +44 20 8715 1722

E-Mail marketingwisepresscom

wwwwisepresscom

Wisepresscom Europersquos leading conference bookseller

has a range of books and journals relevant to the themes of

the meeting In addition to attending 200 conferences per

year Wisepress has a comprehensive medical and scientific

bookshop online with great offers Follow us on Twitter for

the latest news WisepressBooks

GOLD

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

C RSE

ECIO ndash European Conference on Interventional Oncology84

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

8585Notes

Cardiovascular and Interventional Radiological Society of Europe

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide

86 ECIO ndash European Conference on Interventional Oncology

CIRSE Central Office

Neutorgasse 9

1010 Vienna Austria

Phone +43 1 904 2003

Fax +43 1 904 2003 30

E-mail infocirseorg

Web wwwecioorg

The ECIO 2016 Pocket Guide

In case of any queries or comments

please contact us at infocirseorg

copy Cardiovascular and Interventional Radiological Society of

Europe 2016

GraphX by L O O P E N T E R P R I S E S media

wwwloop-enterprisescom

Imprint

  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide
  • Important Addresses
  • Committees
  • General Information from A to Z
  • Honorary Lecture
  • Hands-on Workshops
  • Sunday April 17
  • Monday April 18
  • Tuesday April 19
  • Wednesday April 20
  • Satellite Symposia
  • Hands-on Workshop Sponsors
  • Sponsors
  • Technical Exhibition (Alphabetical List)
  • Technical Exhibition (Numerical List)
  • Technical Exhibitors Guide